Steve Pollitt
Corporate Officer/Principal bij Trinity Biosystems, Inc.
Profiel
Dr. Steve Pollitt is Vice President-Process Sciences at Trinity Biosystems, Inc. and a Member at Sand Hill Angels, Inc.
Dr. Pollitt was previously employed as a Professor by University of Medicine & Dentistry of New Jersey.
He received his undergraduate degree from the University of Georgia and a doctorate degree from Purdue University.
Actieve functies van Steve Pollitt
| Bedrijven | Functie | Begin |
|---|---|---|
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 18-09-2009 |
Eerdere bekende functies van Steve Pollitt
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
Opleiding van Steve Pollitt
| Purdue University | Doctorate Degree |
| University of Georgia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | Health Technology |
